These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 570744)

  • 21. [Factor IX inhibitor (antihemophilic factor B, PTC) in a woman].
    Hule V
    Vnitr Lek; 1975 Mar; 21(3):274-7. PubMed ID: 1119107
    [No Abstract]   [Full Text] [Related]  

  • 22. Structure and function of protein C.
    Stenflo J
    Semin Thromb Hemost; 1984 Apr; 10(2):109-21. PubMed ID: 6429858
    [No Abstract]   [Full Text] [Related]  

  • 23. Human coagulation factor IX. Isolation and characterization.
    Suomela H
    Eur J Biochem; 1976 Dec; 71(1):145-54. PubMed ID: 827443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the thrombogenicity of Scottish factor IX concentrates in dogs.
    Cash JD; Dalton RG; Middleton S; Smith JK
    Thromb Diath Haemorrh; 1975 Jun; 33(3):632-9. PubMed ID: 1154318
    [No Abstract]   [Full Text] [Related]  

  • 25. Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations.
    Kempton CL; Hoffman M; Roberts HR; Monroe DM
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):861-6. PubMed ID: 15653564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and characterization of an abnormal factor IX (Christmas factor) molecule. Factor IX Chapel Hill.
    Chung KS; Madar DA; Goldsmith JC; Kingdon HS; Roberts HR
    J Clin Invest; 1978 Nov; 62(5):1078-85. PubMed ID: 711853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Degradation of coagulation proteins by an enzyme from Malayan pit viper (Akistrodon rhodostoma) venom.
    Lollar P; Parker CG; Kajenski PJ; Litwiller RD; Fass DN
    Biochemistry; 1987 Dec; 26(24):7627-36. PubMed ID: 3322404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.
    Castillo MJ; Kurachi K; Nishino N; Ohkubo I; Powers JC
    Biochemistry; 1983 Mar; 22(5):1021-9. PubMed ID: 6601494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X.
    Osterud B; Miller-Andersson M; Abildgaard U; Prydz H
    Thromb Haemost; 1976 Apr; 35(2):295-304. PubMed ID: 61631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired factor-IX inhibitor in a nonhaemophilic patient with autoimmune disease.
    Largo R; Sigg P; von Felten A; Straub PW
    Br J Haematol; 1974 Jan; 26(1):129-40. PubMed ID: 4211775
    [No Abstract]   [Full Text] [Related]  

  • 31. Kinetic studies of the activation of factor X by factors IXa and VIII:C in the absence of thrombin.
    Neal GG; Esnouf MP
    Br J Haematol; 1984 May; 57(1):123-31. PubMed ID: 6426496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment.
    Cooper HA; Reisner FF; Hall M; Wagner RH
    J Clin Invest; 1975 Sep; 56(3):751-60. PubMed ID: 1080490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombosis and blood coagulation. A study by quantitative N-terminal amino acid analysis.
    Smith GF; Murray M
    Arch Pathol; 1970 Mar; 89(3):235-46. PubMed ID: 4984497
    [No Abstract]   [Full Text] [Related]  

  • 34. The coagulation of blood: preliminary survey of thrombin and autoprothrombin zymogen structure.
    Seegers WH; Murano G; McCoy L; Marciniak E
    Life Sci; 1969 Sep; 8(18):925-32. PubMed ID: 5346943
    [No Abstract]   [Full Text] [Related]  

  • 35. Bovine factor IX (Christmas factor). Further evidence of homology with factor X (Stuart factor) and prothrombin.
    Enfield DL; Ericsson LH; Fujikawa K; Titani K; Walsh KA; Neurath H
    FEBS Lett; 1974 Oct; 47(1):132-5. PubMed ID: 4473377
    [No Abstract]   [Full Text] [Related]  

  • 36. Factor IX of the blood coagulation system: a review.
    Taran LD
    Biochemistry (Mosc); 1997 Jul; 62(7):685-93. PubMed ID: 9331959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring once-weekly recombinant factor IX prophylaxis in hemophilia B with thrombin generation assay and factor IX activity.
    Nummi V; Jouppila A; Lassila R
    Int J Lab Hematol; 2017 Aug; 39(4):359-368. PubMed ID: 28406575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.
    Orstavik KH
    Thromb Haemost; 1981 Dec; 46(4):684-6. PubMed ID: 7330818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of factor IX bound to cultured bovine aortic endothelial cells.
    Stern DM; Drillings M; Kisiel W; Nawroth P; Nossel HL; LaGamma KS
    Proc Natl Acad Sci U S A; 1984 Feb; 81(3):913-7. PubMed ID: 6608105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of intrinsic or extrinsic blood coagulation in experimental venous thrombosis and disseminated intravascular coagulation: pathogenetic differences.
    Gurewich V; Nunn T; Lipinski B
    Thromb Res; 1979; 14(6):931-40. PubMed ID: 473128
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.